Analyzing the permissible scope of an injunction under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit reversed the ...

As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...

- First ASXL1 Pediatric Acute Myeloid Leukemia (AML) Patient Dosed at MD Anderson Cancer Center: Program Supported by Rare Pediatric Disease Designation (RPDD) ...

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.

On Thursday, 2637 stocks advanced, 1327 declined and 151 remained unchanged on Bombay Stock Exchange with advance decline ...

CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ:CING) reported first quarter 2025 results on May 8 th , 2025.

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

It was pointed out that it takes a long time to apply health insurance for innovative new drugs in Korea. This is the result ...